News of Note—FluGen, Roswell Park Cancer Institute and The Vaccine Group

FluGen rounds up more cash, FDA awards a new orphan drug designation and The Vaccine Group forms.

> Madison, Wisconsin-based FluGen reeled in $5.5 million as it prepares for three tests on a universal flu vaccine candidate next year. Xconomy story

> The FDA awarded an orphan drug designation for a glioblastoma vaccine candidate developed at the Roswell Park Cancer Institute. Release

> A spinoff from the University of Plymouth dubbed The Vaccine Group formed to work on vaccines against pathogens such as avian influenza A, Ebola and Marburg viruses, MERS and SARS. Release